Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
Shruti Gupta, Salim S. Hayek, Wei Wang, et al.
JAMA Internal Medicine (2020) Vol. 180, Iss. 11, pp. 1436-1436
Open Access | Times Cited: 928

Showing 1-25 of 928 citing articles:

Post-acute COVID-19 syndrome
Ani Nalbandian, Kartik Sehgal, Aakriti Gupta, et al.
Nature Medicine (2021) Vol. 27, Iss. 4, pp. 601-615
Open Access | Times Cited: 4261
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Carlos Salama, Jian Han, Linda Yau, et al.
New England Journal of Medicine (2020) Vol. 384, Iss. 1, pp. 20-30
Open Access | Times Cited: 1175
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease
David Halpin, Gerard J. Criner, Alberto Papi, et al.
American Journal of Respiratory and Critical Care Medicine (2020) Vol. 203, Iss. 1, pp. 24-36
Open Access | Times Cited: 620
COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup
Mitra K. Nadim, Lui G. Forni, Ravindra L. Mehta, et al.
Nature Reviews Nephrology (2020) Vol. 16, Iss. 12, pp. 747-764
Open Access | Times Cited: 613
Frequent neurologic manifestations and encephalopathy‐associated morbidity in Covid‐19 patients
Eric M. Liotta, Ayush Batra, Jeffrey R. Clark, et al.
Annals of Clinical and Translational Neurology (2020) Vol. 7, Iss. 11, pp. 2221-2230
Open Access | Times Cited: 501
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
Shruti Gupta, Wei Wang, Salim S. Hayek, et al.
JAMA Internal Medicine (2020) Vol. 181, Iss. 1, pp. 41-41
Open Access | Times Cited: 498
Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis
Adam Booth, Angus B. Reed, Sonia Ponzo, et al.
PLoS ONE (2021) Vol. 16, Iss. 3, pp. e0247461-e0247461
Open Access | Times Cited: 480
Global pandemics interconnected — obesity, impaired metabolic health and COVID-19
Norbert Stefan, Andreas L. Birkenfeld, Matthias B. Schulze
Nature Reviews Endocrinology (2021) Vol. 17, Iss. 3, pp. 135-149
Open Access | Times Cited: 414
Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection
Laura Montefusco, Moufida Ben Nasr, Francesca D’Addio, et al.
Nature Metabolism (2021) Vol. 3, Iss. 6, pp. 774-785
Open Access | Times Cited: 357
Association of Psychiatric Disorders With Mortality Among Patients With COVID-19
Katlyn Nemani, Chenxiang Li, Mark Olfson, et al.
JAMA Psychiatry (2021) Vol. 78, Iss. 4, pp. 380-380
Open Access | Times Cited: 350
Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies
Kamal S. Saini, Marco Tagliamento, Matteo Lambertini, et al.
European Journal of Cancer (2020) Vol. 139, pp. 43-50
Open Access | Times Cited: 318
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis
Thibault Fiolet, Anthony Guihur, Mathieu E. Rebeaud, et al.
Clinical Microbiology and Infection (2020) Vol. 27, Iss. 1, pp. 19-27
Open Access | Times Cited: 295
Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis
Farha Musharrat Noor, Md. Momin Islam
Journal of Community Health (2020) Vol. 45, Iss. 6, pp. 1270-1282
Open Access | Times Cited: 293
The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis
Karla Romero Starke, David Reissig, Gabriela Petereit-Haack, et al.
BMJ Global Health (2021) Vol. 6, Iss. 12, pp. e006434-e006434
Open Access | Times Cited: 289
AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19
Shruti Gupta, Steven G. Coca, Lili Chan, et al.
Journal of the American Society of Nephrology (2020) Vol. 32, Iss. 1, pp. 161-176
Open Access | Times Cited: 263
Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2
Francesca Salamanna, Melania Maglio, Maria Paola Landini, et al.
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 253
Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury
Jia Hwei Ng, Jamie S. Hirsch, Azzour D. Hazzan, et al.
American Journal of Kidney Diseases (2020) Vol. 77, Iss. 2, pp. 204-215.e1
Open Access | Times Cited: 249
COPD and the risk of poor outcomes in COVID-19: A systematic review and meta-analysis
Firoozeh V. Gerayeli, Stephen Milne, Chung Yan Cheung, et al.
EClinicalMedicine (2021) Vol. 33, pp. 100789-100789
Open Access | Times Cited: 245
Variation in US Hospital Mortality Rates for Patients Admitted With COVID-19 During the First 6 Months of the Pandemic
David A. Asch, Natalie E. Sheils, Md Nazmul Islam, et al.
JAMA Internal Medicine (2020) Vol. 181, Iss. 4, pp. 471-471
Open Access | Times Cited: 228
COVID-19 Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider
Caroline M. Hsu, Daniel E. Weiner, Gideon Aweh, et al.
American Journal of Kidney Diseases (2021) Vol. 77, Iss. 5, pp. 748-756.e1
Open Access | Times Cited: 224
Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States
Jennifer E. Flythe, Magdalene M. Assimon, Matthew J. Tugman, et al.
American Journal of Kidney Diseases (2020) Vol. 77, Iss. 2, pp. 190-203.e1
Open Access | Times Cited: 216
Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative
Tellen D. Bennett, Richard A. Moffitt, Janos Hajagos, et al.
JAMA Network Open (2021) Vol. 4, Iss. 7, pp. e2116901-e2116901
Open Access | Times Cited: 208
Risk Factors Associated With All-Cause 30-Day Mortality in Nursing Home Residents With COVID-19
Orestis A. Panagiotou, Cyrus M. Kosar, Elizabeth M. White, et al.
JAMA Internal Medicine (2021) Vol. 181, Iss. 4, pp. 439-439
Open Access | Times Cited: 200
Epidemiology of SARS-CoV-2
Bernd Salzberger, Felix Buder, Benedikt Lampl, et al.
Infection (2020) Vol. 49, Iss. 2, pp. 233-239
Open Access | Times Cited: 193
Clinical Characteristics and Outcomes of COVID-19–Infected Cancer Patients: A Systematic Review and Meta-Analysis
Hua Zhang, Han Han, Tianhui He, et al.
JNCI Journal of the National Cancer Institute (2020) Vol. 113, Iss. 4, pp. 371-380
Open Access | Times Cited: 193
Page 1 - Next Page

Scroll to top